Angela C. Collins

Angela C. Collins

Auto-generated profile, based on publicly available information

Angela C. Collins

Department of Orthopaedic Surgery, McLaren Regional Medical Center, Flint, Michigan

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2013 in Nature
Verified
Journal Article
Open access
PDF file
PMPaolo S. Manzanillo
Paolo S. Manzanillo
JAJanelle S. Ayres
Janelle S. Ayres
RWRobert O. Watson
Robert O. Watson
ACAngela C. Collins
Angela C. Collins
GSGianne Souza
Gianne Souza
JCJeffery S. Cox
Jeffery S. Cox
Ubiquitin-mediated targeting of intracellular bacteria to the autophagy pathway is a key innate defence mechanism against invading microbes, including the important human pathogen Mycobacterium tuberculosis. However, the ubiquitin ligases responsible for catalysing ubiquitin chains that surround intracellular bacteria are poorly understood. The parkin protein is a ubiquitin ligase with a well-established role in mitophagy, and mutations in the parkin gene (PARK2) lead to increased susceptibility to Parkinson’s disease. Surprisingly, genetic polymorphisms in the PARK2 regulatory region are also associated with increased susceptibility to intracellular bacterial pathogens in humans, including Mycobacterium leprae and Salmonella enterica serovar Typhi, but the function of parkin in immunity has remained unexplored. Here we show that parkin has a role in ubiquitin-mediated autophagy of M. tuberculosis. Both parkin-deficient mice and flies are sensitive to various intracellular bacterial infections, indicating parkin has a conserved role in metazoan innate defence. Moreover, our work reveals an unexpected functional link between mitophagy and infectious disease.

1 June 2015 in Cell Host & Microbe
Verified
Journal Article
Closed access
ACAngela C. Collins
Angela C. Collins
HCHaocheng Cai
Haocheng Cai
TLTuo Li
Tuo Li
Luis Henrique FrancoLuis Henrique Franco
Luis Henrique Franco
XLXiao-Dong Li
Xiao-Dong Li
MSMichael U. Shiloh
Michael U. Shiloh

20 February 2015 in Immunological Reviews
Verified
Journal Article
Closed access
PDF file
CSChelsea E. Stamm
Chelsea E. Stamm
ACAngela C. Collins
Angela C. Collins
MSMichael U. Shiloh
Michael U. Shiloh

1 June 2016 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
CSCaitlyn R. Scharn
Caitlyn R. Scharn
ACAngela C. Collins
Angela C. Collins
VNVidhya R. Nair
Vidhya R. Nair
CSChelsea E Stamm
Chelsea E Stamm
DMDenise K. Marciano
Denise K. Marciano
MSMichael U. Shiloh
Michael U. Shiloh
Mycobacterium tuberculosis, the causative agent of tuberculosis, is responsible for 1.5 million deaths annually. We previously showed that M. tuberculosis infection in mice induces expression of the CO-producing enzyme heme oxygenase (HO1) and that CO is sensed by M. tuberculosis to initiate a dormancy program. Further, mice deficient in HO1 succumb to M. tuberculosis infection more readily than do wild-type mice. Although mouse macrophages control intracellular M. tuberculosis infection through several mechanisms, such as NO synthase, the respiratory burst, acidification, and autophagy, how human macrophages control M. tuberculosis infection remains less well understood. In this article, we show that M. tuberculosis induces and colocalizes with HO1 in both mouse and human tuberculosis lesions in vivo, and that M. tuberculosis induces and colocalizes with HO1 during primary human macrophage infection in vitro. Surprisingly, we find that chemical inhibition of HO1 both reduces inflammatory cytokine production by human macrophages and restricts intracellular growth of mycobacteria. Thus, induction of HO1 by M. tuberculosis infection may be a mycobacterial virulence mechanism to enhance inflammation and bacterial growth.

1 June 2018 in Heliyon
Verified
Journal Article
Open access
ACAngela Collins
Angela Collins
EWEdward K. Wakeland
Edward K. Wakeland
PRPrithvi Raj
Prithvi Raj
MKMin S. Kim
Min S. Kim
JKJiwoong Kim
Jiwoong Kim
LCLawson A.B. Copley
Lawson A.B. Copley
Children with acute hematogenous osteomyelitis (AHO) have a broad spectrum of illness ranging from mild to severe. The purpose of this study is to evaluate the impact of genomic variation of Staphylococcus aureus on clinical phenotype of affected children and determine which virulence genes correlate with severity of illness. De novo whole genome sequencing was conducted for a strain of Community Acquired Methicillin Resistant Staphylococcus aureus (CA-MRSA), using PacBio Hierarchical Genome Assembly Process (HGAP) from 6 Single Molecule Real Time (SMRT) Cells, as a reference for DNA library assembly of 71 Staphylococcus aureus isolates from children with AHO. Virulence gene annotation was based on exhaustive literature review and genomic data in NCBI for Staphylococcus aureus. Clinical phenotype was assessed using a validated severity score. Kruskal-Wallis rank sum test determined association between clinical severity and virulence gene presence using False Discovery Rate (FDR), significance <0.01. PacBio produced an assembled genome of 2,898,306 bp and 2054 Open Reading Frames (ORFs). Annotation confirmed 201 virulence genes. Statistical analysis of gene presence by clinical severity found 40 genes significantly associated with severity of illness (FDR ≤0.009). MRSA isolates encoded a significantly greater number of virulence genes than did MSSA (p < 0.0001). Phylogenetic analysis by maximum likelihood (PAML) demonstrated the relatedness of genomic distance to clinical phenotype. The Staphylococcus aureus genome contains virulence genes which are significantly associated with severity of illness in children with osteomyelitis. This study introduces a novel reference strain and detailed annotation of Staphylococcus aureus virulence genes. While this study does not address bacterial gene expression, a platform is created for future transcriptome investigations to elucidate the complex mechanisms involved in childhood osteomyelitis.

5 October 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HSHyun-Jin Shin
Hyun-Jin Shin
Luis Henrique FrancoLuis Henrique Franco
Luis Henrique Franco
VNVidhya R. Nair
Vidhya R. Nair
ACAngela C. Collins
Angela C. Collins
MSMichael U. Shiloh
Michael U. Shiloh
Mycobacterium tuberculosis, the causative agent of tuberculosis, is a major cause of morbidity and mortality worldwide. However, an effective vaccine for M. tuberculosis is lacking. We panned a phage display library using monoclonal antibodies against M. tuberculosis liporabinomannan (LAM), an important component of the M. tuberculosis cell wall, and identified two peptide sequences, HSFKWLDSPRLR or SGVYKVAYDWQH, with high antibody affinity after multiple rounds of panning. Only the HSFKWLDSPRLR peptide induced an anti-LAM response when conjugated to either keyhole limpet hemocyanin (KLH) or to the baculovirus Autographa californica multicapsid nucleopolyherovirus (AcMNPV) when introduced into mice by injection or via intranasal inoculation, respectively. Vaccination with AcMNPV conjugated HSFKWLDSPRLR peptide delayed mortality in a mouse model of tuberculosis. Thus, we report a proof of principle M. tuberculosis vaccination strategy combining an anti-LAM mimotope with a baculovirus delivery system.